Amferia
Manufacturing · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Pepparedsleden 1, Moelndal, Vaestra Goet...Phone Number
+46 762981238Website
www.amferia.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Amferia
Amferia's antimicrobial amphiphilic hydrogel kills bacteria, even resistant bacteria without harming the body. The material was developed through several years of research in collaboration with Chalmers University of Technology and the first product from this technology platform is a wound-care dressing for dry-to-low exuding wounds.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amferia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Amferia launches new products
Congratulate Masked Content for being promoted to Masked Content at Amferia
Check out if Amferia is spiking on competitors!
Earning: See what the market has to say on Amferia recently announced quarterly report
Website visits: Recent activity has been detected on your website
Amferia, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Amferia had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Amferia has new funding data
Check if Amferia has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Amferia as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Amferia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amferia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amferia.
Amferia financials insights
Gather financial insights about Amferia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$1.3M
Amferia Tech Stack
A closer look at the technologies used by Amferia
See more technologies
Amferia News & Media
Amferia Recognized on Ny Teknik’s Prestigious “33-listan” for Second Consecutive Year
The significance of being on the list a second time highlights Amferia's continued growth and increasing market potential. It suggests that the company has not only managed to sustain its initial success but has also demonstrated the ability to expand and strengthen its position within the industry. Being recognized again reflects a track record of strong performance, innovation, or strategic decisions that make Amferia a promising company for future growth. Amferia has once again earnedAmferia wins Red Dot Award for Innovative Design addressing bacterial infections and antibiotic resistance
Swedish medtech company Amferia has been awarded the Red Dot Award for its elevator pitch logotype in the Brand & Communication Design category. The new logo describes the company’s innovation and purpose in three words: Amferia kills bacteria. ”The award highlights our commitment to addressing bacterial infections and antibiotic resistance. Amferia’s innovation contributes to the solution, but we also have to communicate that in an innovative way to reach a global audience.” says Anand RajasekhFirst Product Utilizing Amferia Antimicrobial Technology Launched in Europe for Animal Wound Care
The Snögg BactiDefend Dressing, a new product in animal wound care using Amferia’s proprietary antimicrobial technology, has been launched for professional veterinary use across several European countries. [image] The introduction of BactiDefend is the result of a partnership between Amferia and Orkla Wound Care, released under Orkla’s Snögg Animal Care brand. This collaboration aims to address the growing need for effective wound care and bacterial reduction in wounds of both small and large anAmferia closes €1,2 million investment to combat resistant bacterial infections
Swedish medtech company Amferia announces the successful completion of its latest investment round, boosting its mission to combat wound infections. During 2024, Amferia has signed important commercial agreements with leading animal health companies in Europe for commercialization of the company’s proprietary technology — a wound dressing for animals that also kills resistant bacteria. Mölndal, Sweden (September 3rd, 2024): Amferia, a Swedish medtech company focused on developing innovative anti
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amferia
Sign Up For FreeTo access detailed company insights
Amferia's antimicrobial amphiphilic hydrogel kills bacteria, even resistant bacteria without harming the body. The material was developed through several years of research in collaboration with Chalmers University of Technology and the first product from this technology platform is a wound-care dressing for dry-to-low exuding wounds.... Read More
